These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7899741)

  • 1. Survival of patients with advanced HIV infection treated with 300 mg/d of zidovudine: a prospective study.
    Ruiz-Argüelles GJ; Lagunes-Yannelli B; Mercado-Díaz L; Alemán-Hoey DD
    Rev Invest Clin; 1994; 46(6):491-3. PubMed ID: 7899741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Low doses of azidothymidine in the treatment of HIV-1 virus infection].
    Lobato-Mendizábal E; Ruiz-Argüelles GJ
    Rev Invest Clin; 1992; 44(2):161-8. PubMed ID: 1359619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
    Vella S; Lazzarin A; Carosi G; Sinicco A; Armignacco O; Angarano G; Andreoni M; Tambussi G; Chiodera A; Floridia M; Scaccabarozzi S; Facey K; Duncan I; Boudes P; Bragman K
    Antivir Ther; 1996 Aug; 1(3):129-40. PubMed ID: 11322246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
    Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
    Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Zidovudine plus didanosine in HIV infected asymptomatic patients previously treated with zidovudine].
    López-Martínez C; Guarner J; Magis-Rodríguez C; Uribe-Zúñiga P; del Río-Chiriboga C
    Rev Invest Clin; 1998; 50(4):335-9. PubMed ID: 9830323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zidovudine and lamivudine: results of phase III studies.
    Staszewski S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyclovir in combination with zidovudine does not prolong survival in advanced HIV disease.
    Erbelding EJ; Chaisson RE; Gallant JE; Moore RD
    Antivir Ther; 1997 Apr; 2(2):71-7. PubMed ID: 11322278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in T-cell subpopulations during four years of suppression of HIV-1 replication in patients with advanced disease.
    Lepej SZ; Begovac J; Vince A
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):351-9. PubMed ID: 16553807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical modelling of chemotherapy in HIV infection.
    Hraba T; Dolezal J
    Folia Biol (Praha); 1994; 40(3):103-11. PubMed ID: 7805931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance hemodialysis in patients with HIV-associated nephropathy.
    Dave MB; Shabih K; Blum S
    Clin Nephrol; 1998 Dec; 50(6):367-74. PubMed ID: 9877110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of long-term follow-up of HIV-infected patients treated with lamivudine monotherapy, followed by a combination of lamivudine and zidovudine.
    van Leeuwen R; Lange JM; Nijhuis M; Schuurman R; Reiss P; Danner SA; Boucher CA
    Antivir Ther; 1997 Apr; 2(2):79-90. PubMed ID: 11322279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
    Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
    J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azidothymidine (AZT) in the treatment of symptomatic HIV-1-infected hemophiliacs.
    Eichinger S; Pabinger I; Hartl H; Stain C; Mayerhofer S; Schweiger C; Kier P; Schwarzinger I; Kyrle PA; Lechner K
    Thromb Haemost; 1990 Aug; 64(1):108-12. PubMed ID: 1980381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection.
    Nightingale SD; Jockusch JD; Haslund I; Cal SX; Peterson DM; Loss SD
    Arch Intern Med; 1993 Jun; 153(11):1313-8. PubMed ID: 8099477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethoprim-sulfamethoxazole exposure alters ex vivo function of B lymphocytes isolated from human immunodeficiency virus-infected patients receiving Zidovudine.
    Venugopalan V; Thornton AC; Steinke DT; Rapp RP; Romanelli F; Feola DJ
    Pharmacotherapy; 2009 Apr; 29(4):373-82. PubMed ID: 19323617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.
    Justice AC; Stein DS; Fusco GP; Sherrill BH; Fusco JS; Danehower SC; Becker SL; Hansen NI; Graham NM;
    J Clin Epidemiol; 2004 Jan; 57(1):89-97. PubMed ID: 15019015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
    Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M
    Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 90K (Mac-2 BP) predicts CD4 decline in human immunodeficiency virus-infected patients with CD4 counts above 200 x 10(6) cells/L.
    Tinari N; Natoli C; D'Ostilio N; Ghinelli F; Sighinolfi L; Ortona L; Tamburrini E; Piazza M; Chirianni A; Guerra L; Di Gregorio P; Iacobelli S
    Arch Pathol Lab Med; 1998 Feb; 122(2):178-81. PubMed ID: 9499363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sequential dideoxycytidine and zidovudine in advanced HIV-1 infection. Phase II study].
    Ruiz-Argüelles GJ; Lagunes-Yannelli B; Mercado-Díaz L
    Rev Invest Clin; 1993; 45(2):145-7. PubMed ID: 8393211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of the survival benefit of zidovudine therapy in HIV infection.
    Moore RD; Keruly JC; Chaisson RE
    Arch Intern Med; 1996 May; 156(10):1073-7. PubMed ID: 8638994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.